双鹭药业：公司目前已进一步加强了风控管理

Core Viewpoint - The company has announced that its performance forecast data is preliminary and that it is currently assessing investment losses, having made significant provisions to mitigate risks [1] Financial Management - The company has proactively made large provisions to fully release risks associated with investment losses [1] - The chairman has committed to cover the irretrievable loss portion of the investment, with an initial contribution of 50 million yuan to the company within a month [1] Risk Management - The company has strengthened its risk control management in response to the situation [1] - The company will disclose further details based on the progress of assessments and investigations [1] Operational Status - The company currently has ample cash reserves and normal production operations, indicating that the situation will not affect other business activities [1]